ADV ACT logo color.jpg
Occlusion Perfusion Catheter Demonstrates Superior Performance in PAD Drug Delivery
02 nov. 2023 08h28 HE | Advanced Catheter Therapies
Researchers successfully demonstrate the delivery of liquid sirolimus into the arterial wall using the OPC, which can also be used for paclitaxel BTK.
MicrosoftTeams-image (1).png
The Global Feminine Hygiene (disposable sanitary pad, reusable pad, tampons, menstrual cup, panty liner, internal cleansers & sprays, disposable razor & blades) Market to Surpass USD 58 Billion by 2027: Bonafide Research
10 févr. 2023 02h00 HE | Bonafide Research & Marketing Pvt. Ltd.
Clifton, New Jersey, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The change in female buying patterns, e-commerce penetration, influence through social media platforms, endorsements by famous celebrities,...
Endonovo Therapeutics Releases Comparative Analysis Demonstrating
28 juil. 2022 09h08 HE | Endonovo Therapeutics, Inc.
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior...
Endonovo Therapeutics Announces LOI to Acquire Specialty Construction Company
09 juin 2022 14h02 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, June 09, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today announced a Letter of Intent to purchase a highly-regarded market leading specialty concrete services...
$5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursement
11 avr. 2022 09h08 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, April 11, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced significant advancement in the of process to obtain medical reimbursements for its...
Endonovo Therapeutics Inc. (ENDV) Announces it has filed a Regulation A+ Financing & Retained Dalmore Group to Provide Operations & Compliance
16 févr. 2022 09h10 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTC-ENDV) an Innovative Medical Devices developer and distributor is pleased to announce it has filed a Regulation A+...
Spotlight on Peripheral Artery Disease And Assessing Leg Pain
24 sept. 2020 13h21 HE | Society for Vascular Surgery
Rosemont, Il., Sept. 24, 2020 (GLOBE NEWSWIRE) -- It is natural to experience growing aches and pains with age – a tightness in your lower back after standing for long periods of time, a crick in...
Endonovo Therapeutics Reports Third Quarter 2019 Results
19 nov. 2019 16h35 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Cabot Microelectronics Corporation Logo
Cabot Microelectronics Corporation to Participate in Société de Chimie Industrielle Monthly Luncheon
28 oct. 2019 19h00 HE | Cabot Microelectronics Corporation
Aurora, IL, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Cabot Microelectronics Corporation (Nasdaq: CCMP), a leading global supplier of consumable materials to semiconductor manufacturers and pipeline...
Sorrento Therapeutics Expands Resiniferatoxin (RTX) Clinical Development Program to Life-Threatening Cardiovascular Diseases With Completion of Major Animal Toxicology Study
15 avr. 2019 04h00 HE | Sorrento Therapeutics, Inc.
SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that its Neuro-Therapeutics unit is pursuing clinical development of resiniferatoxin...